Gisele Dion's Insider Trades & SAST Disclosures
Gisele Dion's most recent trade in Inhibikase Therapeutics Inc was a trade of 30,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on July 16, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Gisele Dion.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Inhibikase Therapeutics Inc | Gisele Dion | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2024 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Inhibikase Therapeutics Inc | Gisele Dion | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 6,667 | 6,667 | - | - | Stock Option (right to buy) | |
| Cytek BioSciences Inc | Gisele Dion | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 30,242 | 30,242 | - | - | Stock Option (right to buy) | |
| Inhibikase Therapeutics Inc | Gisele Dion | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Cytek BioSciences Inc | Gisele Dion | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 25,789 | 25,789 | - | - | Stock Option (right to buy) | |
| Cytek BioSciences Inc | Gisele Dion | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 22 Jul 2021 | 5,000 | 5,000 | - | 17 | 85,000 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges